“Impact of HIV subtype on response and resistance in antiretroviral-naïve adults comparing treatment with once daily versus twice daily ritonavir boosted fosamprenavir in combination with Abacavir/Lamivudine” (2011) Drugs and Therapy Studies, 2(1), p. e1. doi:10.4081/dts.2012.e1.